Fidelity Investments’s Oruka Therapeutics ORKA Stock Holding History

Fidelity Investments’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$862M	Buy	9,057,645 +1,626,242	+22%	+$108M	0.04%	362
2026 Q1	$365M	Buy	7,431,403 +170,019	+2%	+$5.91M	0.02%	631
2025 Q4	$220M	Buy	7,261,384 +3,763	+0.1%	+$105K	0.01%	831
2025 Q3	$140M	Buy	7,257,621 +1,641,150	+29%	+$24.3M	0.01%	1022
2025 Q2	$63M	Buy	5,616,471 +54,663	+1%	+$570K	﹤0.01%	1301
2025 Q1	$57.1M	Buy	5,561,808 +49,508	+0.9%	+$617K	﹤0.01%	1306
2024 Q4	$107M	Buy	5,512,300 +830,000	+18%	+$20.2M	0.01%	1094
2024 Q3	$115M	Buy	+4,682,300	New	+$163M	0.01%	1046
2024 Q2	–	Sell	-17	Closed	-$358	–	5679
2024 Q1	$358	Buy	+17	New	+$338	﹤0.01%	4873
2019 Q4	–	Sell	-2	Closed	–	–	4333
2019 Q3	$0	Buy	+2	New	+$147	﹤0.01%	4293

Other funds holding ORKA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Fidelity Investments's ORKA Position: Q2 2026 in Review

Fidelity Investments increased its Oruka Therapeutics (ORKA) stake by 22% in Q2 2026, buying an estimated $108M and bringing the position to 9,057,645 shares worth $862M. The position accounts for 0.04% of the portfolio, ranked #362.

Fidelity Investments first reported a position in ORKA in Q3 2019 and has held it in 10 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Fidelity Investments held 9,057,645 shares of Oruka Therapeutics worth $862M as of Q2 2026.
Fidelity Investments bought 1,626,242 Oruka Therapeutics shares in Q2 2026, an estimated $108M.
Oruka Therapeutics made up 0.04% of Fidelity Investments's portfolio in Q2 2026, its #362 holding.
Fidelity Investments first reported a position in Oruka Therapeutics in Q3 2019 and has held it in 10 quarters since.
256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.